Use of statistics to assess the global burden of breast cancer

被引:287
作者
Parkin, DM [1 ]
Fernández, LMG
机构
[1] Univ Oxford, Dept Publ Hlth & Primary Care, Clin Trials Serv Unit, Oxford OX3 7LF, England
[2] Univ Oxford, Dept Publ Hlth & Primary Care, Epidemiol Studies Unit, Oxford OX3 7LF, England
[3] Natl Inst Oncol, Havana, Cuba
关键词
breast cancer; burden of illness; health care evaluation mechanisms; health planning; outcomes assessment; program evaluation; registries; resource allocation; statistics;
D O I
10.1111/j.1075-122X.2006.00205.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A variety of statistics are used to quantify the burden (occurrence and outcome) of cancer generally and of breast cancer specifically. When undertaking any cancer control program, understanding these statistics, their source, and their quality is important for assessing the current situation, allocating resources to different control strategies, and evaluating progress. Two core statistics are the cancer incidence rate and the cancer mortality rate, which provide estimates of the average risk of acquiring and of dying from the disease, respectively. About 16% of the world's population is covered by registration systems that produce cancer incidence statistics, while mortality data are available for about 29%. Breast cancer incidence and mortality vary considerably by world region. In general, the incidence is high (greater than 80 per 100,000) in developed regions of the world and low (less than 30 per 100,000), though increasing, in developing regions; the range of mortality rates is much less (approximately 6-23 per 100,000) because of the more favorable survival of breast cancer in (high-incidence) developed regions. The incidence of breast cancer is increasing almost everywhere. This unfavorable trend is due in part to increases in risk factors (decreased childbearing and breast-feeding, increased exogenous hormone exposure, and detrimental dietary and lifestyle changes, including obesity and less physical activity). On the other hand, mortality is now decreasing in many high-risk countries due to a combination of intensified early detection efforts and the introduction of mammographic screening, resulting in the diagnosis of more small, early stage tumors, and advances in treatment.
引用
收藏
页码:S70 / S80
页数:11
相关论文
共 64 条
  • [1] Armstrong W, 1996, NEW ZEAL MED J, V109, P221
  • [2] Bergström A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt
  • [3] ::AID-IJC1053&gt
  • [4] 3.0.CO
  • [5] 2-T
  • [6] Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality
    Blanks, RG
    Moss, SM
    McGahan, CE
    Quinn, MJ
    Babb, PJ
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7262) : 665 - 669
  • [7] Breast cancer incidence and mortality trends in 16 European countries
    Botha, JL
    Bray, F
    Sankila, R
    Parkin, DM
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) : 1718 - 1729
  • [8] The changing global patterns of female breast cancer incidence and mortality
    Bray, F
    McCarron, P
    Parkin, DM
    [J]. BREAST CANCER RESEARCH, 2004, 6 (06) : 229 - 239
  • [9] Brinton LA, 1997, INT J CANCER, V73, P349, DOI 10.1002/(SICI)1097-0215(19971104)73:3<349::AID-IJC8>3.0.CO
  • [10] 2-#